JOAN COLLINS TURNED HEADS AS SHE STEPPED OUT FOR A ROSÉ LAUNCH EVENT, JOINED BY HER HUSBAND PERCY GIBSON. (PHOTO).

Image
 Joan Collins: Rosé season has arrived… I never wait for permission to pour A touch of pink, a hint of glamour, and unmistakable presence, Joan Collins turned heads as she stepped out for a rosé launch event, joined by her husband Percy Gibson. The veteran actress, now in her 90s, looked effortlessly elegant in a coordinated pale pink outfit that mirrored the theme of the occasion. Standing beside a towering rosé display, she embraced the moment with her usual charm, declaring that the season for the popular wine had officially begun. “Rosé season has arrived,” she said with a smile, adding that she has never needed a reason to enjoy a glass. In her words, good taste matters more than location, noting that one doesn’t need a South of France backdrop to enjoy quality wine. Her appearance carried more than just style. It also reflected her long-standing approach to beauty and wellness. Speaking recently, Collins made it clear she has no interest in weight-loss injections or cosmetic ...

KENYA HAILS FIRST ROLLOUT OF HIV PREVENTION DRUG LENACAPAVIR. (PHOTO).


 Kenya hails first rollout of HIV prevention drug Lenacapavir


Kenya began administering the first dose of a groundbreaking HIV prevention drug in a Nairobi slum on Thursday.


Lenacapavir, taken twice a year, has been shown to reduce the risk of HIV transmission by more than 99.9 percent, though it is technically a chemical drug rather than a vaccine because it does not train the immune system.


"Today is a moment of hope for thousands of Kenyan families," Health Minister Aden Duale said during the rollout, AFP reported.


Kenya was among nine African countries selected last year to introduce lenacapavir, which has already been introduced in South Africa, Eswatini and Zambia since December.


There are roughly 1.3 million people living with HIV in Kenya, with the highest burden among those aged 15 to 24.


‘Renewed strength’


"Many of our young people still face the risk of infection... this innovation gives us renewed strength in our national fight against HIV," Duale, said adding that the drug will be free to those receiving it.


Last week, Kenya received its first batch of 21,000 doses through a deal with lenacapavir's manufacturer, Gilead Sciences, and the Global Fund to Fight AIDS.


Lenacapavir offers greater privacy compared to regularly visits to health clinics for treatment, said Carol Njomo, a community health worker in Nairobi's Kawangware area, where the first doses were administered.


"This is an added protection," said Samson Mutua, 27, the first person to receive the injection.

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).